drugset
drugset / Trial / NCT00663481

A Clinical Trial of CoFactor Formulations and Leucovorin Administered Intravenously in Healthy, Adult Subjects.

NCT00663481 ↗

Phase 1 Completed 15 enrolled Mast Therapeutics, Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to determine the safety and tolerability of CoFactor in healthy subjects.

Timeline

Start
2008-04
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject FOLITIXORIN Small molecule — Intravenous
Comparator Leucovorin Small molecule — Intravenous

Indications

No indication recorded.